The PACeR Gold - Multiplex Pathogen Identification Platform for Detection of Mycobacterium Tuberculosis Infections.

Award Information
Agency:
Department of Defense
Branch
n/a
Amount:
$149,299.00
Award Year:
2012
Program:
SBIR
Phase:
Phase I
Contract:
FA8650-12-M-6253
Award Id:
n/a
Agency Tracking Number:
O112-H05-3066
Solicitation Year:
2011
Solicitation Topic Code:
OSD11-H05
Solicitation Number:
2011.2
Small Business Information
2113 Wells Branch Parkway, Suite 6900, Austin, TX, -
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
Y
Duns:
084994735
Principal Investigator:
James Lulo
Principal Investigator
(512) 782-8218
james@accaciabio.com
Business Contact:
Eula Sequeira
President
(512) 782-8218
eula29@gmail.com
Research Institute:
Stub




Abstract
The World Health Organization estimates that more than one-third of the worldwide population is infected with Mycobacterium tuberculosis (MTB), the causative agent of most cases of tuberculosis (TB). Patients who are infected with MTB, but do not have active TB disease have latent tuberculosis infection (LTBI), a non-communicable, asymptomatic condition which might develop into active TB disease months or years later. Early diagnosis of LTBI is critical for the management, containment, and prophylactic treatment necessary in order to prevent active disease and future epidemics. We propose to develop the novel PACeR-Gold multiplex pathogen identification platform for sequence-specific MTB-derived nucleic acid detection. The PACeR-Gold assay will be optimized in Phase I and incorporated into an accurate, automated, and user-friendly device for assay performance and detection during Phase II. We will develop a uniform PACeR-Gold instrument platform with a plug-and-play system of disposable assay cartridges for early, specific, and rapid detection of MTB DNA. Our"closed"cartridge system allows for consistent and reproducible results, eliminates the risk for amplicon contamination in the assay, and does not require highly trained operators. The PACeR-Gold diagnostic platform will be continuously expanded to include assays to detect nontuberculous mycobacteria, multidrug-resistant-TB, extensively drug-resistant-TB, and other MTB variants.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government